- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 213/46 - Atomes d'oxygène
Détention brevets de la classe C07D 213/46
Brevets de cette classe: 107
Historique des publications depuis 10 ans
|
8
|
8
|
3
|
7
|
6
|
9
|
4
|
1
|
6
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Purdue Pharma L.P. | 519 |
6 |
| The Regents of the University of California | 18943 |
4 |
| F. Hoffmann-La Roche AG | 7958 |
3 |
| Merck Patent GmbH | 5909 |
3 |
| Merck Serono SA | 126 |
3 |
| Corteva Agriscience LLC | 2494 |
3 |
| Roche Diagnostics GmbH | 2745 |
2 |
| Roche Diagnostics Operations, Inc. | 1375 |
2 |
| Syngenta Participations AG | 4970 |
2 |
| BioMarin Pharmaceutical Inc. | 368 |
2 |
| Board of Trustees of Southern Illinois University | 100 |
2 |
| CHDI Foundation, Inc. | 104 |
2 |
| InterMune, Inc. | 97 |
2 |
| Northeastern University | 1056 |
2 |
| Targacept, Inc. | 63 |
2 |
| The United States Government AS represented by The Department of Veterans Affairs | 949 |
2 |
| Vanderbilt University | 1731 |
2 |
| Inflazome Limited | 92 |
2 |
| Landos Biopharma, Inc. | 36 |
2 |
| Mitsui Chemicals Crop & Life Solutions,Inc. | 142 |
2 |
| Autres propriétaires | 57 |